# Learn | Resources to take control of your cancer

Explore articles on personalized treatment options, clinical trials,
and symptom management to empower every step of your journey.

### [The 5 Best Apps for Breast Cancer Patients](/content/best-app-breast-cancer/index.html)

Find the best app for breast cancer patients to track symptoms, manage treatment, and get support. Discover top-rated tools for your care and peace of mind.

- December 21, 2025

### [Metastatic Prostate Cancer Survival Rate: What It Means](/content/metastatic-prostate-cancer-survival-rate/index.html)

Get clear answers about the metastatic prostate cancer survival rate, what affects your outlook, and how treatment and lifestyle choices can make a difference.

- December 20, 2025

### [6 Best Cancer Treatment & Symptom Tracker Apps](/content/cancer-treatment-symptom-tracker/index.html)

Find the best cancer treatment and symptom tracker app to organize your care, track symptoms, and support better communication with your healthcare team.

- December 20, 2025

### [Top 5 Best Apps for Managing Cancer Symptoms](/content/best-app-managing-cancer-symptoms/index.html)

Find the best app for managing cancer symptoms with these top picks. Track side effects, get reminders, and connect with support—all from your phone.

- December 19, 2025

### [5 Best Apps for Breast Cancer Symptom Tracking](/content/best-app-breast-cancer-tracking/index.html)

Find the best app for breast cancer symptom tracking with these top picks. Stay organized, track symptoms, and support your health with easy-to-use tools.

- December 18, 2025

### [NSCLC First Line Treatment: What You Need to Know](/content/first-line-treatment-nsclc/index.html)

Get clear answers on NSCLC first line treatment, including options, side effects, and how biomarker testing shapes your personalized lung cancer care plan.

- December 08, 2025

### [Part 4: Dosing, guidelines, and support](/content/article/part-4-dosing-guidelines-and-support/index.html)

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...

- December 02, 2025

### [Part 3: Effectiveness and Safety of ORSERDU (elacestrant)](/content/article/part-3-effectiveness-and-safety-of-orserdu/index.html)

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...

- December 02, 2025

### [Part 2: The Emerald Trial](/content/article/part-2-the-emerald-trial/index.html)

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...

- December 02, 2025

### [Part 1: Understanding ESR1 mutations](/content/article/part-1-understanding-esr1-mutations/index.html)

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...

- December 02, 2025

### [The DYNASTY-Breast02 Trial](/content/article/the-dynasty-breast02-trial/index.html)

You may be potentially eligible for the DYNASTY Breast-02 Clinical trial. To learn more information,...

- August 07, 2025

"Participating in a clinical trial was not only a valuable part of my treatment plan...

- March 04, 2025

### [Ask the Expert: 2024 San Antonio Breast Cancer Symposium Highlights](/content/cancer-topic/breast-cancer/ask-the-expert-2024-san-antonio-breast-cancer-symposium-highlights/index.html)

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...

- December 19, 2024

### [Breaking Down the Latest Prostate Cancer Treatment Options](/content/cancer-topic/prostate-cancer/movember-momentum-breaking-down-the-latest-prostate-cancer-options/index.html)

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...

- November 08, 2024

### [Best Exercise For Breast Cancer Survivors](/content/cancer-topic/breast-cancer-survivorship-and-wellness/ask-the-expert-enhancing-quality-of-life-and-outcomes-through-exercise-for-breast-cancer-survivors-and-thrivers/index.html)

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...

- October 21, 2024